Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06010641 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Trendelenburg Position for Acute Anterior Circulation Ischemic Stroke With Large Artery Atherosclerosis Etiology (HOPES 3)

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Oct 30, 2026 to Oct 30, 2027v5
  2. Primary and study completion dates: Oct 30, 2025 to Oct 30, 2026v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Oct 21, 2024 to Oct 30, 2025
    • Start date changed from estimate of Oct 21, 2023 to Jan 10, 2024
    • Site details revised
    v3
  4. Phase: Phase 4 to Not applicablev2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The effect of head position as a nonpharmacological therapy on acute ischemic stroke (AIS) remains inconclusive. Recent HOPES2 (Head dOwn-Position for acutE moderate ischemic Stroke with large artery atherosclerosis) suggest the safety, feasibility, and potential benefit of the head-down position (HDP) in acute ischemic stroke. The current study aims to investigate the efficacy and safety of HDP in acute moderate ischemic stroke patients with large artery atherosclerosis.
Trial Details
NCT Number NCT06010641
Lead Sponsor General Hospital of Shenyang Military Region
Conditions
(from sponsor)		 Stroke, Acute Ischemic
Related terms Ischemic Stroke
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov